Dror Bashan is CEO & President at Protalix BioTherapeutics, Inc. (PLX). They have made 3 open-market trades across 1 company since 2022, most recently 2025-12-19.
CIK 0001781450
3 open-market purchases totalling $362K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PLX | 188,516 | $493K |
Shares reported on the most recent Form 4, priced at the 2025-12-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.